DYRK1B haploinsufficiency in a Holstein cattle with epilepsy

被引:1
|
作者
Jacinto, Joana G. P. [1 ,2 ]
Bolcato, Marilena [1 ]
Haefliger, Irene M. [2 ]
Oevermann, Anna [3 ]
Gentile, Arcangelo [1 ]
Droegemueller, Cord [2 ]
机构
[1] Univ Bologna, Dept Vet Med Sci, Bologna, Italy
[2] Univ Bern, Inst Genet, Vetsuisse Fac, CH-3001 Bern, Switzerland
[3] Univ Bern, Vetsuisse Fac, Div Neurol Sci, DCR VPH, Bern, Switzerland
关键词
cattle; DNA double-strand; idiopathic epilepsy; precision medicine; seizure; TRANSCRIPTION; FAMILY; GENES;
D O I
10.1111/age.13348
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
In this study, epilepsy with focal seizures progressing to generalized seizures was diagnosed in a 6-month- old Holstein heifer. The seizures were characterized by a brief pre-ictal phase with depression and vocalization. During the ictal phase eyelid spasms, tongue contractions, nodding and abundant salivation were observed, rapidly followed by a convulsive phase with bilateral tonic, clonic or tonic-clonic activity and loss of consciousness. Finally, during the postictal phase the heifer was obtunded and disorientated, unable to perceive obstacles and hypermetric, and pressed its head against objects. In the inter- seizure phase, the heifer was clinically normal. Neuropathology revealed axonal degeneration in the brainstem and diffuse astrocytic hypertrophic gliosis. Whole genome sequencing of the affected heifer identified a private heterozygous splice-site variant in DYRK1B (NM_001081515.1: c.-101- 1G> A), most likely resulting in haploinsufficiency owing to loss-of- function. This represents a report of a DYRK1B-associated disease in cattle and adds DYRK1B to the candidate genes for epilepsy.
引用
收藏
页码:623 / 627
页数:5
相关论文
共 50 条
  • [31] The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma
    Deng, Xiaobing
    Ewton, Daina Z.
    Li, Sheena
    Naqvi, Asghar
    Friedman, Eileen
    CANCER RESEARCH, 2006, 66 (08) : 4149 - 4158
  • [32] How to design potent and selective DYRK1B inhibitors? Molecular modeling study
    Szamborska-Gbur, Agnieszka
    Rutkowska, Ewelina
    Dreas, Agnieszka
    Frid, Michael
    Vilenchik, Maria
    Milik, Mariusz
    Brzozka, Krzysztof
    Krol, Marcin
    JOURNAL OF MOLECULAR MODELING, 2019, 25 (02)
  • [33] Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells
    Ewton, Daina Z.
    Hu, Jing
    Vilenchik, Maria
    Deng, Xiaobing
    Luk, Kin-chun
    Polonskaia, Ann
    Hoffman, Ann F.
    Zipf, Karen
    Boylan, John F.
    Friedman, Eileen A.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2104 - 2114
  • [34] Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B
    Yamaguchi, Momoka
    Ohbayashi, Saya
    Ooka, Akira
    Yamashita, Hinako
    Motohashi, Nanami
    Kaneko, Yukiko K.
    Kimura, Toshihide
    Saito, Shin-ya
    Ishikawa, Tomohisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 600 : 136 - 141
  • [35] The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase
    Song, Liang-Nian
    Silva, Jose
    Koller, Antonius
    Rosenthal, Andrew
    Chen, Emily I.
    Gelmann, Edward P.
    MOLECULAR CANCER RESEARCH, 2015, 13 (05) : 913 - 922
  • [36] Functional characterization of two DYRK1B variants causative of AOMS3
    Detro-Dassen, Silvia
    Sternberg, Anna
    Lehmann, Sonja Maria
    Schwandt, Katharina
    Duesterhoeft, Stefan
    Becker, Walter
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [37] DYRK1B MODIFIES INSULIN ACTION IN LIVER AND SKELETAL MUSCLE AND PREDISPOSE TO ATHEROSCLEROSIS
    Fathzadeh, M.
    Keramati, A. R.
    Bazzaz, J. Tavakkoly
    Yarovinsky, T.
    Sarajzadeh, K.
    Amini, M.
    Noorafshan, A.
    Mehrabani, D.
    Dianatpour, M.
    Omrani, G. H. Ranjbar
    Bigi, M. A. Babaee
    Kasaei, M.
    Poustchi, H.
    Lifton, R.
    Malekzadeh, R.
    Mani, A.
    ATHEROSCLEROSIS, 2015, 241 (01) : E23 - E23
  • [38] Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down's Syndrome or Alzheimer's Disease
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 502 - 503
  • [39] How to design potent and selective DYRK1B inhibitors? Molecular modeling study
    Agnieszka Szamborska-Gbur
    Ewelina Rutkowska
    Agnieszka Dreas
    Michael Frid
    Maria Vilenchik
    Mariusz Milik
    Krzysztof Brzózka
    Marcin Król
    Journal of Molecular Modeling, 2019, 25
  • [40] Screen identifies DYRK1B network as mediator of transcription repression on damaged chromatin
    Dong, Chao
    West, Kirk L.
    Tan, Xin Yi
    Li, Junshi
    Ishibashi, Toyotaka
    Yu, Cheng-han
    Sy, Shirley M. H.
    Leung, Justin W. C.
    Huen, Michael S. Y.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (29) : 17019 - 17030